
Brain Tumor Vaccine Shows Cautious Optimism in Long-Term Study
A therapeutic vaccine targeting a specific genetic mutation in aggressive brain tumors has shown promising long-term results in a study of 33 patients. Eight years later, 66% were still alive and 42% showed no tumor regrowth, offering cautious optimism for future treatments.



